

Bazil Azmil
Bazil has over 10 years of experience as a founder and operator in venture-backed companies, focusing on digital health. Bazil was the founder and CEO of Breakthrough Health, maker of Emilyn - the #1 Multiple sclerosis (MS) patient support app. Breakthrough was acquired by Mymee, a New York-based personalised care company, where Bazil served as VP of Business Development. He previously worked at ResearchGate, the world's largest professional network for scientists, and was an EIR at Atlantic Labs, an early-stage VC.
For media inquiries or interview requests, please contact press@antler.co
ARTICLES

Why we invested in Plenex
In 2019, a precise 3D capture of a building cost more than £30,000. Today it costs under £500, and a phone walkthrough gets you most of the way there. Yet the knowledge that runs factories, warehouses and data centres still lives in photos, PDFs, spreadsheets and the heads of the people who walk the floor.

Why we invested in Lir Labs
Aeration (pumping air into tanks so bacteria can break down waste) accounts for around 30% of a wastewater treatment plant's operating cost. Because operators can't see the biology in real time, most over-aerate by 20–30% as a safety buffer. Globally, aeration consumes roughly 1.5% of all energy demand, around $42bn a year. A 15% optimisation would be worth $6.3bn annually.

Why we invested in Ninopay
There is a quiet financial crisis happening in millions of UK households, and it repeats itself every month with very little fanfare. A nursery invoice arrives. It asks for £1,000, £1,500, sometimes £2,000 in full, in advance, before the month has even started. And parents, with very few options, find a way to pay it. Or they don't.


